Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1281.7
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 2 EP applications Gail Wilson McCluskie has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11818261

METHOD FOR PRODUCING DISPERSION OF RUTILE-TYPE TITANIUM OXIDE PARTICLES

IPC classification:
B01J 31/38, G02B 1/04, C01G 23/047, C09C 1/36, C09D 17/00, C08L 101/00, C08K 3/20, C01G 23/053
Applicant:
Sakai Chemical Industry Co Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP10859577

METHOD FOR PRODUCING BIOACTIVE AGENT, BIOACTIVE AGENT PRODUCED THEREBY, COSMETIC, FRESHNESS-MAINTAINING AGENT, GROWTH PROMOTION AGENT, SOIL CONDITIONING AGENT, AND PHARMACEUTICAL STOCK SOLUTION

IPC classification:
C09K 17/40, A23B 7/157, C05D 5/00, A61K 8/67, A23L 3/358, C09K 17/02, A61Q 19/00, A61Q 7/00, A61P 37/08, A61P 35/00, A61P 3/10, A61P 1/16, A61K 33/06, A61K 31/375, A61K 31/355, A61K 31/122, A61K 8/19, A23B 4/027, A61K 33/26
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature